Latest Production News

Gold Road Resources projects a significant production increase at Gruyere in 2025 and has initiated underground drilling to potentially extend mine life beyond 2032.

Astral Resources has reported its most significant diamond drilling results to date at the Theia Deposit within the Mandilla Gold Project, with drill-hole MDRCD918 delivering an exceptional 1,079 gram-metres of gold mineralisation. This breakthrough is expected to underpin an upgrade of the resource classification ahead of a Mineral Resource Estimate update scheduled for March 2025.

Aurora Labs has secured significant contracts in the Defence sector, advancing its micro gas turbine technology and expanding production capabilities following a successful capital raise.

Butn Limited has posted record quarterly revenue and platform originations for Q2 FY25, alongside sustained positive operating cash flow, signaling robust growth and strategic expansion into crypto-backed lending.

First Graphene has secured key patents for its Kainos Technology in Australia and Korea, positioning itself at the forefront of producing graphite, graphene, and hydrogen from petroleum waste. This milestone aligns with growing global demand for critical minerals essential to the energy transition.

Butn Limited reported a modest net cash increase from operating activities in the December 2024 quarter, ending with a strong cash balance of $16.8 million. The fintech company’s latest cash flow report reveals ongoing investment and notable payments to related parties.

AIC Mines delivered a robust December quarter with record copper production at Eloise and promising exploration results at Jericho, underpinning its growth strategy.

Telix Pharmaceuticals has finalized its acquisition of RLS (USA) Inc., significantly expanding its radiopharmaceutical footprint across the United States with a network of over 30 radiopharmacies.

Complii FinTech Solutions Ltd reports a robust Q2 FY25 with a $3.048 million cash balance, a net operational cash inflow, and a 12.9% year-on-year increase in Annual Recurring Revenue, driven by strategic divestment and focused growth initiatives.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Ausgold Limited reports significant progress in its Katanning Gold Project feasibility study, highlighted by strong drilling results and strategic executive appointments, positioning the company for a pivotal 2025.

Stanmore Resources capped off 2024 with record saleable coal production of 13.8 million tonnes, exceeding guidance despite operational headwinds. Strong performances at South Walker Creek and Poitrel, alongside strategic financial moves and a pioneering renewable fuels trial, position the company well for 2025.